Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral Trial
Journal
Blood
Journal Volume
134
Journal Issue
1
Pages
14
Date Issued
2019
Author(s)
Smith C.C.
Levis M.J.
Perl A.E.
Martinelli G.
Neubauer A.
Berman E.
Montesinos P.
Baer M.R.
Larson R.A.
Yokoyama H.
Recher C.
Yoon S.-S.
Hill J.E.
Rosales M.
Bahceci E.
Type
journal article